Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions

Dirk Böse1, Clemens von Birgelen, Xiu Ying Zhou

  • 1Dept. of Cardiology, West German Heart Center, University of Duisburg-Essen, Hufelandstrasse 55, 45122, Essen, Germany. dirk.boese@uk-essen.de

Basic Research in Cardiology
|September 13, 2008
PubMed

Insights

Necrotic core (NC) in coronary plaques, identified by intravascular ultrasound (IVUS) with radiofrequency data (IVUS-RF), predicts cardiac marker release after percutaneous coronary intervention (PCI). Larger NC volumes correlate with increased myocardial injury, aiding risk stratification.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomarkers

Background:

  • Cardiac marker release post-percutaneous coronary intervention (PCI) indicates myocardial necrosis.
  • This necrosis often stems from periprocedural (micro)embolization of atherothrombotic debris.
  • Such events are linked to impaired left ventricular function and adverse outcomes.

Purpose of the Study:

  • To investigate the relationship between coronary plaque composition and microembolization after PCI.
  • To assess if intravascular ultrasound with radiofrequency data (IVUS-RF) can predict cardiac marker release.

Main Methods:

  • Prospective study of 55 patients undergoing direct stenting for single de-novo lesions.
  • Pre-PCI plaque composition analyzed using IVUS-RF (Virtual Histology).
  • Serial measurements of cardiac markers (creatine kinase and troponin I) before and up to 24 hours after PCI.

Main Results:

  • Plaque necrotic core (NC) volume significantly correlated with the maximum increase in cardiac markers (CK and CTnI).
  • Patients with larger NC volumes (>10.8 mm(3)) showed a particularly high increase in cardiac markers.
  • Total plaque volume and other plaque components (fibrous, fibro-fatty, calcium) did not correlate with cardiac marker release.

Conclusions:

  • Large necrotic cores in culprit lesions are associated with greater myocardial injury due to peri-interventional microembolization.
  • IVUS-RF assessment before PCI can identify high-risk lesions.
  • This identification may help tailor PCI strategies to minimize myocardial damage.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...